title: Sweet syndrome developing during treatment with all-trans retinoic acid in a child with acute myelogenous leukemia.
abstract: Acute febrile neutrophilic dermatosis (Sweet syndrome) has been reported in a few adults receiving all-trans retinoic acid for acute promyelocytic leukemia. The authors report a case of Sweet syndrome associated with the administration of all-trans retinoic acid for acute promyelocytic leukemia in a pediatric patient.
authors.affiliation: Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, ON M5G 1X8, Canada.
authors.forename: Khulood
authors.initials: K
authors.lastname: Al-Saad
authors.forename: Muhammad Faisal
authors.initials: MF
authors.lastname: Khanani
authors.forename: Ahmed
authors.initials: A
authors.lastname: Naqvi
authors.forename: Bernice
authors.initials: B
authors.lastname: Krafchik
authors.forename: Ron
authors.initials: R
authors.lastname: Grant
authors.forename: Alberto
authors.initials: A
authors.lastname: Pappo
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D002648:Child; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D012867:Skin / Q000473:pathology; D016463:Sweet Syndrome / Q000139:chemically induced* / Q000473:pathology; D016896:Treatment Outcome; D014212:Tretinoin / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D014212:Tretinoin